comparemela.com

Latest Breaking News On - Sciences int l - Page 1 : comparemela.com

CK Life Sciences to present Cancer Vaccine data at the 2024 American Association for Cancer Research (AACR) Annual Meeting

<div> HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach Newswire</a> - 5 April 2024 - CK Life Sciences Int’l., (Holdings) Inc. will be presenting new data from its cancer vaccine research pipeline at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, California, USA.</div>

Wex Pharmaceuticals Inc Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers Sensory Perceptions

Wex Pharmaceuticals Inc Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers Sensory Perceptions
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Wex Pharmaceuticals Inc Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron on Healthy Volunteers Sensory Perceptions

Wex Pharmaceuticals Inc Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron on Healthy Volunteers Sensory Perceptions
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 1 November 2023 - CK Life Sciences Int l., (Holdings) Inc. is presenting preclinical data for its investigational dual-antigen cancer vaccines, co-targeting PRAME (preferentially expressed antigen in melanoma) and PD-L1 (programmed death-ligand 1), on November 4<b> </b>at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California, USA.</p>

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.